Related Experiment Videos
Genes contributing to Alzheimer's disease
R Sandbrink1, T Hartmann, C L Masters
1Center for Molecular Biology Heidelberg (ZMBH), University of Heidelberg, Germany.
Molecular Psychiatry
|March 1, 1996
Summary
Alzheimer's disease (AD) is proposed as a single condition driven by a common APP-beta A4-amyloid pathway. Genetic mutations in PS1, PS2, and APP genes, along with APOE epsilon 4, increase AD risk.
Area of Science:
- Neuroscience
- Genetics
- Metabolic pathways
Background:
- Alzheimer's disease (AD) pathogenesis is complex, involving genetic and environmental factors.
- Familial AD with complete penetrance is increasingly understood at the molecular genetic level.
Purpose of the Study:
- To propose Alzheimer's disease as a single entity unified by a common metabolic pathway.
- To review identified genetic and other factors that induce this pathway.
- To discuss the interplay of genetic risk factors and APP metabolism in AD.
Main Methods:
- Review of molecular genetics studies on familial AD.
- Analysis of genetic mutations in PS1, PS2, and APP genes.
- Examination of genetic risk factors including APOE, ACT-A, VLDL-R, HLA-A, and mitochondrial mutations.
Main Results:
- Missense mutations in PS1, PS2, and APP genes explain the majority of autosomal dominant familial AD.
- The APOE epsilon 4 allele is a significant risk factor for late-onset and sporadic AD.
- Other genetic factors like ACT-A, VLDL-R, HLA-A, and potential mitochondrial mutations also contribute to AD risk.
Conclusions:
- Alzheimer's disease can be viewed as a single disease process centered on the APP-beta A4-amyloid pathway.
- Understanding genetic underpinnings, from rare familial mutations to common risk alleles, is crucial for AD research.
- APP metabolism, influenced by genetic factors and signaling pathways, is central to AD development.